Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept

Bibliographic Details
Main Authors:	Henry Alistair I, Gong Haiping, Nesbitt Andrew M
Format:	Article
Language:	English
Published:	BMC 2011-11-01
Series:	Journal of Translational Medicine

Similar Items

Reverse signalling of membrane TNF in human natural killer cells: a comparison of the effect of certolizumab pegol and other anti-TNF agents
by: Fossati Gianluca, et al.
Published: (2011-11-01)

Certolizumab pegol in the treatment of spondyloarthritis
by: Mariusz Korkosz
Published: (2014-09-01)

Certolizumab pegol in therapy for rheumatoid arthritis
by: Galina Viktorovna Lukina, et al.
Published: (2012-06-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-02-01)

Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation
by: Matt Stevenson, et al.
Published: (2016-04-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva, et al.
Published: (2015-10-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
by: Mehmet Baysal, et al.
Published: (2018-09-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
by: M Connock, et al.
Published: (2010-10-01)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
by: Monika Hebeisen, et al.
Published: (2019-01-01)

Experience with long-term use of certolizumab pegol (Cimzia)
by: Karine Arnoldovna Lytkina, et al.
Published: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
by: Karine Arnoldovna Lytkina, et al.
Published: (2013-10-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
by: I L Khalif, et al.
Published: (2018-04-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
by: Maria Majdan, et al.
Published: (2014-07-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
by: Ranatunga S, et al.
Published: (2014-02-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
by: Piotr Wiland, et al.
Published: (2011-08-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
by: I.L. Khalif, et al.
Published: (2018-04-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
by: Vera Nikolayevna Amirdjanova, et al.
Published: (2012-10-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
by: P. I. Novikov, et al.
Published: (2018-07-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
by: Yael Sharon, et al.
Published: (2020-06-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
by: O V Knyazev, et al.
Published: (2018-06-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
by: Wojciech Blonski, et al.
Published: (2012-01-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
by: Wojciech Blonski, et al.
Published: (2012-04-01)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013-07-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
by: Emna Hannech, et al.
Published: (2021-06-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019-12-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
by: R. Talotta, et al.
Published: (2016-09-01)

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
by: M Rodgers, et al.
Published: (2011-02-01)

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
by: C McLeod, et al.
Published: (2007-08-01)

Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis Hepatotoxicidad recurrente asociada a etanercept y adalimumab pero no a infliximab en una paciente con artritis reumatoide
by: José Carlos Titos-Arcos, et al.
Published: (2012-05-01)

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
by: Nesbitt A, et al.
Published: (2010-11-01)

Avaliação econômica das anticitocinas adalimumabe, etanercepte e infliximabe no tratamento da artrite reumatoide no Estado do Paraná Economic evaluation of anticitokines adalimumab, etanercept and infliximab for treatment of rheumatoid arthritis in Paraná State, Brazil
by: Rafael Venson, et al.
Published: (2011-01-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
by: Dmitry Evgenyevich Karateev, et al.
Published: (2012-04-01)

Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy
by: Marin J, et al.
Published: (2018-05-01)

Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris
by: Keiko Yamaguchi, et al.
Published: (2018-12-01)

New biologics in the management of Crohn&rsquo;s disease: focus on certolizumab pegol
by: Elisabetta Colombo, et al.
Published: (2009-06-01)

Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
by: Syuichi Koarada, et al.
Published: (2015-01-01)

Severe interstitial lung disease following treatment with certolizumab pegol: a case report
by: Jakob Lager, et al.
Published: (2013-09-01)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
by: Acosta-Felquer ML, et al.
Published: (2016-03-01)

Certolizumab Pegol-Induced Folliculitis-Like Lichenoid Sarcoidosis in a Patient with Rheumatoid Arthritis
by: Hiroyuki Sakai, et al.
Published: (2017-09-01)